{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:05:11Z","timestamp":1773795911961,"version":"3.50.1"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T00:00:00Z","timestamp":1310601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11481-011-9296-1","type":"journal-article","created":{"date-parts":[[2011,7,13]],"date-time":"2011-07-13T11:57:29Z","timestamp":1310558249000},"page":"477-489","source":"Crossref","is-referenced-by-count":47,"title":["Opioids and HIV\/HCV Infection"],"prefix":"10.1007","volume":"6","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Zhe","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,14]]},"reference":[{"key":"9296_CR1","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.22534","volume":"48","author":"CK Aitken","year":"2008","unstructured":"Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, Drummer H, Hellard M (2008) High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 48:1746\u20131752","journal-title":"Hepatology"},{"key":"9296_CR2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/clinids\/20.6.1467","volume":"20","author":"P Alcabes","year":"1995","unstructured":"Alcabes P, Friedland G (1995) Injection drug use and human immunodeficiency virus infection. Clin Infect Dis 20:1467\u20131479","journal-title":"Clin Infect Dis"},{"key":"9296_CR3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0891-5520(02)00018-1","volume":"16","author":"NC Alonzo","year":"2002","unstructured":"Alonzo NC, Bayer BM (2002) Opioids, immunology, and host defenses of intravenous drug abusers. Infect Dis Clin North Am 16:553\u2013569","journal-title":"Infect Dis Clin North Am"},{"key":"9296_CR4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","volume":"341","author":"MJ Alter","year":"1999","unstructured":"Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556\u2013562","journal-title":"N Engl J Med"},{"key":"9296_CR5","doi-asserted-by":"crossref","first-page":"e2516","DOI":"10.1371\/journal.pone.0002516","volume":"3","author":"P Ancuta","year":"2008","unstructured":"Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3:e2516","journal-title":"PLoS One"},{"key":"9296_CR6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1348-0421.2006.tb03824.x","volume":"50","author":"H Asakura","year":"2006","unstructured":"Asakura H, Kawamoto K, Igimi S, Yamamoto S, Makino S (2006) Enhancement of mice susceptibility to infection with Listeria monocytogenes by the treatment of morphine. Microbiol Immunol 50:543\u2013547","journal-title":"Microbiol Immunol"},{"key":"9296_CR7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1024603517136","volume":"18","author":"M Backmund","year":"2003","unstructured":"Backmund M, Meyer K, Wachtler M, Eichenlaub D (2003) Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity. Eur J Epidemiol 18:563\u2013568","journal-title":"Eur J Epidemiol"},{"key":"9296_CR8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1157\/13060891","volume":"122","author":"S Bassani","year":"2004","unstructured":"Bassani S, Toro C, de la Fuente L, Brugal MT, Jimenez V, Soriano V (2004) Rate of infection by blood-borne viruses in active heroin users in 3 Spanish cities. Medicina Clinica 122:570\u2013572","journal-title":"Medicina Clinica"},{"key":"9296_CR9","first-page":"21","volume":"40","author":"RJ Battjes","year":"1988","unstructured":"Battjes RJ, Leukefeld CG, Pickens RW, Haverkos HW (1988) The acquired immunodeficiency syndrome and intravenous drug abuse. Bull Narc 40:21\u201334","journal-title":"Bull Narc"},{"key":"9296_CR10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0028-3908(90)90096-A","volume":"29","author":"BM Bayer","year":"1990","unstructured":"Bayer BM, Daussin S, Hernandez M, Irvin L (1990) Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 29:369\u2013374","journal-title":"Neuropharmacology"},{"key":"9296_CR11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/viro.1998.9130","volume":"244","author":"M Beld","year":"1998","unstructured":"Beld M, Penning M, Lukashov V, McMorrow M, Roos M, Pakker N, van den Hoek A, Goudsmit J (1998) Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 244:504\u2013512","journal-title":"Virology"},{"key":"9296_CR12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1360-0443.1995.tb02231.x","volume":"90","author":"J Bell","year":"1995","unstructured":"Bell J, Chan J, Kuk A (1995) Investigating the influence of treatment philosophy on outcome of methadone maintenance. Addiction 90:823\u2013830","journal-title":"Addiction"},{"key":"9296_CR13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","volume":"30","author":"Y Benhamou","year":"1999","unstructured":"Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30:1054\u20131058","journal-title":"Hepatology"},{"key":"9296_CR14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/CDLI.7.5.719-723.2000","volume":"7","author":"JM Bidlack","year":"2000","unstructured":"Bidlack JM (2000) Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol 7:719\u2013723","journal-title":"Clin Diagn Lab Immunol"},{"key":"9296_CR15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1089\/jir.2006.26.834","volume":"26","author":"JT Blackard","year":"2006","unstructured":"Blackard JT, Kang M, Sherman KE, Koziel MJ, Peters MG, Chung RT (2006) Effects of HCV treatment on cytokine expression during HCV\/HIV coinfection. J Interferon Cytokine Res 26:834\u2013838","journal-title":"J Interferon Cytokine Res"},{"key":"9296_CR16","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1128\/JCM.43.4.1937-1939.2005","volume":"43","author":"AF Bobkov","year":"2005","unstructured":"Bobkov AF, Selimova LM, Khanina TA, Zverev SY, Pokrovsky VV, Weber JN, Bobkov EN, Rylkov AV (2005) Human immunodeficiency virus type 1 in illicit-drug solutions used intravenously retains infectivity. J Clin Microbiol 43:1937\u20131939","journal-title":"J Clin Microbiol"},{"key":"9296_CR17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2893.1999.00153.x","volume":"6","author":"M Bonacini","year":"1999","unstructured":"Bonacini M, Govindarajan S, Blatt LM, Schmid P, Conrad A, Lindsay KL (1999) Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat 6:203\u2013208","journal-title":"J Viral Hepat"},{"key":"9296_CR18","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/j.1572-0241.2008.02065.x","volume":"103","author":"HL Bonkovsky","year":"2008","unstructured":"Bonkovsky HL, Tice AD, Yapp RG, Bodenheimer HC Jr, Monto A, Rossi SJ, Sulkowski MS (2008) Efficacy and safety of peginterferon alfa-2a\/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration. Am J Gastroenterol 103:2757\u20132765","journal-title":"Am J Gastroenterol"},{"key":"9296_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/clinids\/23.1.107","volume":"23","author":"A Boschini","year":"1996","unstructured":"Boschini A, Smacchia C, Di Fine M, Schiesari A, Ballarini P, Arlotti M, Gabrielli C, Castellani G, Genova M, Pantani P, Lepri AC, Rezza G (1996) Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis 23:107\u2013113","journal-title":"Clin Infect Dis"},{"key":"9296_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/mi.2007.1","volume":"1","author":"JM Brenchley","year":"2008","unstructured":"Brenchley JM, Douek DC (2008a) HIV infection and the gastrointestinal immune system. Mucosal Immunol 1:23\u201330","journal-title":"Mucosal Immunol"},{"key":"9296_CR21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/COH.0b013e3282f9ae9c","volume":"3","author":"JM Brenchley","year":"2008","unstructured":"Brenchley JM, Douek DC (2008b) The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 3:356\u2013361","journal-title":"Curr Opin HIV AIDS"},{"key":"9296_CR22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","volume":"200","author":"JM Brenchley","year":"2004","unstructured":"Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200:749\u2013759","journal-title":"J Exp Med"},{"key":"9296_CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ni1316","volume":"7","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Douek DC (2006a) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7:235\u2013239","journal-title":"Nat Immunol"},{"key":"9296_CR24","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC (2006b) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12:1365\u20131371","journal-title":"Nat Med"},{"key":"9296_CR25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/gut.2008.163287","volume":"59","author":"R Bruno","year":"2010","unstructured":"Bruno R, Galastri S, Sacchi P, Cima S, Caligiuri A, DeFranco R, Milani S, Gessani S, Fantuzzi L, Liotta F, Frosali F, Antonucci G, Pinzani M, Marra F (2010) gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut 59:513\u2013520","journal-title":"Gut"},{"key":"9296_CR26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002030-199204000-00013","volume":"6","author":"E Chamot","year":"1992","unstructured":"Chamot E, de Saussure P, Hirschel B, Deglon JJ, Perrin LH (1992) Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS 6:430\u2013431","journal-title":"AIDS"},{"key":"9296_CR27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0022-3565(25)19959-X","volume":"252","author":"CC Chao","year":"1990","unstructured":"Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK (1990) Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther 252:605\u2013609","journal-title":"J Pharmacol Exp Ther"},{"key":"9296_CR28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0006-2952(95)00176-Z","volume":"50","author":"CC Chao","year":"1995","unstructured":"Chao CC, Gekker G, Hu S, Sheng WS, Portoghese PS, Peterson PK (1995) Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem Pharmacol 50:715\u2013722","journal-title":"Biochem Pharmacol"},{"key":"9296_CR29","first-page":"364","volume":"108","author":"J Chetwynd","year":"1995","unstructured":"Chetwynd J, Brunton C, Blank M, Plumridge E, Baldwin D (1995) Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. N Z Med J 108:364\u2013366","journal-title":"N Z Med J"},{"key":"9296_CR30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature04076","volume":"436","author":"FV Chisari","year":"2005","unstructured":"Chisari FV (2005) Unscrambling hepatitis C virus-host interactions. Nature 436:930\u2013932","journal-title":"Nature"},{"key":"9296_CR31","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1074\/jbc.M512438200","volume":"281","author":"SH Choi","year":"2006","unstructured":"Choi SH, Hwang SB (2006) Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein. J Biol Chem 281:7468\u20137478","journal-title":"J Biol Chem"},{"key":"9296_CR32","doi-asserted-by":"crossref","first-page":"G847","DOI":"10.1152\/ajpgi.00522.2005","volume":"290","author":"J Choi","year":"2006","unstructured":"Choi J, Ou JH (2006) Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 290:G847\u2013G851","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9296_CR33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1006\/bbrc.1993.2167","volume":"195","author":"LF Chuang","year":"1993","unstructured":"Chuang LF, Killam KF Jr, Chuang RY (1993a) Increased replication of simian immunodeficiency virus in CEM x174 cells by morphine sulfate. Biochem Biophys Res Commun 195:1165\u20131173","journal-title":"Biochem Biophys Res Commun"},{"key":"9296_CR34","first-page":"573","volume":"86","author":"RY Chuang","year":"1993","unstructured":"Chuang RY, Blackbourne DJ, Chuang LF (1993b) Modulation of simian AIDS by opioids. Adv Biosci 86:573\u2013583","journal-title":"Adv Biosci"},{"key":"9296_CR35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-4615-1951-5_24","volume":"373","author":"RY Chuang","year":"1995","unstructured":"Chuang RY, Chuang LF, Li Y, Kung HF, Killam KF Jr (1995) SIV mutations detected in morphine-treated Macaca mulatta following SIVmac239 infection. Adv Exp Med Biol 373:175\u2013181","journal-title":"Adv Exp Med Biol"},{"key":"9296_CR36","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2741\/1651","volume":"10","author":"RY Chuang","year":"2005","unstructured":"Chuang RY, Suzuki S, Chuang TK, Miyagi T, Chuang LF, Doi RH (2005) Opioids and the progression of simian AIDS. Front Biosci 10:1666\u20131677","journal-title":"Front Biosci"},{"key":"9296_CR37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa032653","volume":"351","author":"RT Chung","year":"2004","unstructured":"Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C (2004) Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 351:451\u2013459","journal-title":"N Engl J Med"},{"key":"9296_CR38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/00002030-199510000-00003","volume":"9","author":"B Cribier","year":"1995","unstructured":"Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F (1995) High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 9:1131\u20131136","journal-title":"AIDS"},{"key":"9296_CR39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1360-0443.1997.tb02979.x","volume":"92","author":"N Crofts","year":"1997","unstructured":"Crofts N, Nigro L, Oman K, Stevenson E, Sherman J (1997) Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction 92:999\u20131005","journal-title":"Addiction"},{"key":"9296_CR40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/0959523031000154463","volume":"22","author":"C Day","year":"2003","unstructured":"Day C, Ross J, Dolan K (2003) Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? Drug Alcohol Rev 22:317\u2013321","journal-title":"Drug Alcohol Rev"},{"key":"9296_CR41","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.162.18.2125","volume":"162","author":"A Luca De","year":"2002","unstructured":"De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D\u2019Arminio Monforte A (2002) Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med 162:2125\u20132132","journal-title":"Arch Intern Med"},{"key":"9296_CR42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1073858403259950","volume":"10","author":"JA DeLeo","year":"2004","unstructured":"DeLeo JA, Tanga FY, Tawfik VL (2004) Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance\/hyperalgesia. Neuroscientist 10:40\u201352","journal-title":"Neuroscientist"},{"key":"9296_CR43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2105\/AJPH.91.1.23","volume":"91","author":"T Diaz","year":"2001","unstructured":"Diaz T, Des Jarlais DC, Vlahov D, Perlis TE, Edwards V, Friedman SR, Rockwell R, Hoover D, Williams IT, Monterroso ER (2001) Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 91:23\u201330","journal-title":"Am J Public Health"},{"key":"9296_CR44","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1001\/jama.260.20.3025","volume":"260","author":"VP Dole","year":"1988","unstructured":"Dole VP (1988) Implications of methadone maintenance for theories of narcotic addiction. Jama 260:3025\u20133029","journal-title":"Jama"},{"key":"9296_CR45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0960-5428(06)80057-4","volume":"3","author":"RM Donahoe","year":"1993","unstructured":"Donahoe RM (1993) Neuroimmunomodulation by opiates: relationship to HIV infection and AIDS. Adv Neuroimmunol 3:31\u201346","journal-title":"Adv Neuroimmunol"},{"key":"9296_CR46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2003.10.011","volume":"147","author":"RM Donahoe","year":"2004","unstructured":"Donahoe RM (2004) Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model. J Neuroimmunol 147:28\u201332","journal-title":"J Neuroimmunol"},{"key":"9296_CR47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-5728(97)00224-5","volume":"83","author":"RM Donahoe","year":"1998","unstructured":"Donahoe RM, Vlahov D (1998) Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 83:77\u201387","journal-title":"J Neuroimmunol"},{"key":"9296_CR48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4615-2980-4_4","volume":"335","author":"RM Donahoe","year":"1993","unstructured":"Donahoe RM, Byrd LD, McClure HM, Fultz P, Brantley M, Marsteller F, Ansari AA, Wenzel D, Aceto M (1993) Consequences of opiate-dependency in a monkey model of AIDS. Adv Exp Med Biol 335:21\u201328","journal-title":"Adv Exp Med Biol"},{"key":"9296_CR49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAI.0b013e3181967354","volume":"50","author":"RM Donahoe","year":"2009","unstructured":"Donahoe RM, O\u2019Neil SP, Marsteller FA, Novembre FJ, Anderson DC, Lankford-Turner P, McClure HH (2009) Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque\/SIVsmm9 model. J Acquir Immune Defic Syndr 50:241\u2013249","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9296_CR50","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1046\/j.1360-0443.1998.939139310.x","volume":"93","author":"AJ Durante","year":"1998","unstructured":"Durante AJ, Selwyn PA, O\u2019Connor PG (1998) Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment. Addiction 93:1393\u20131401","journal-title":"Addiction"},{"key":"9296_CR51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11481-006-9019-1","volume":"1","author":"TK Eisenstein","year":"2006","unstructured":"Eisenstein TK, Rahim RT, Feng P, Thingalaya NK, Meissler JJ (2006) Effects of opioid tolerance and withdrawal on the immune system. J Neuroimmune Pharmacol 1:237\u2013249","journal-title":"J Neuroimmune Pharmacol"},{"key":"9296_CR52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2006.05.027","volume":"178","author":"N El-Hage","year":"2006","unstructured":"El-Hage N, Wu G, Ambati J, Bruce-Keller AJ, Knapp PE, Hauser KF (2006a) CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. J Neuroimmunol 178:9\u201316","journal-title":"J Neuroimmunol"},{"key":"9296_CR53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/glia.20262","volume":"53","author":"N El-Hage","year":"2006","unstructured":"El-Hage N, Wu G, Wang J, Ambati J, Knapp PE, Reed JL, Bruce-Keller AJ, Hauser KF (2006b) HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53:132\u2013146","journal-title":"Glia"},{"key":"9296_CR54","doi-asserted-by":"crossref","first-page":"e4093","DOI":"10.1371\/journal.pone.0004093","volume":"3","author":"N El-Hage","year":"2008","unstructured":"El-Hage N, Bruce-Keller AJ, Yakovleva T, Bazov I, Bakalkin G, Knapp PE, Hauser KF (2008) Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription. PLoS One 3:e4093","journal-title":"PLoS One"},{"key":"9296_CR55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/08820139.2011.561904","volume":"40","author":"N El-Hage","year":"2011","unstructured":"El-Hage N, Podhaizer EM, Sturgill J, Hauser KF (2011) Toll-like receptor expression and activation in Astroglia: differential regulation by HIV-1 Tat, gp120, and morphine. Immunol Invest 40:498\u2013522","journal-title":"Immunol Invest"},{"key":"9296_CR56","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3181\/0711-RM-294","volume":"233","author":"A El-Sharif","year":"2008","unstructured":"El-Sharif A, Ashour HM (2008) Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers. Exp Biol Med (Maywood) 233:874\u2013880","journal-title":"Exp Biol Med (Maywood)"},{"key":"9296_CR57","first-page":"602","volume":"6","author":"ME Eyster","year":"1993","unstructured":"Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ (1993) Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 6:602\u2013610","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9296_CR58","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-3565(25)12317-3","volume":"276","author":"K Fecho","year":"1996","unstructured":"Fecho K, Maslonek KA, Dykstra LA, Lysle DT (1996) Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther 276:626\u2013636","journal-title":"J Pharmacol Exp Ther"},{"key":"9296_CR59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2005.03.017","volume":"164","author":"P Feng","year":"2005","unstructured":"Feng P, Meissler JJ Jr, Adler MW, Eisenstein TK (2005) Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12. J Neuroimmunol 164:57\u201365","journal-title":"J Neuroimmunol"},{"key":"9296_CR60","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejphar.2006.01.048","volume":"534","author":"P Feng","year":"2006","unstructured":"Feng P, Rahim RT, Cowan A, Liu-Chen LY, Peng X, Gaughan J, Meissler JJ Jr, Adler MW, Eisenstein TK (2006a) Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit. Eur J Pharmacol 534:250\u2013257","journal-title":"Eur J Pharmacol"},{"key":"9296_CR61","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1128\/IAI.00208-06","volume":"74","author":"P Feng","year":"2006","unstructured":"Feng P, Truant AL, Meissler JJ Jr, Gaughan JP, Adler MW, Eisenstein TK (2006b) Morphine withdrawal lowers host defense to enteric bacteria: spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection. Infect Immun 74:5221\u20135226","journal-title":"Infect Immun"},{"key":"9296_CR62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","volume":"16","author":"H Friedman","year":"2003","unstructured":"Friedman H, Newton C, Klein TW (2003) Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 16:209\u2013219","journal-title":"Clin Microbiol Rev"},{"key":"9296_CR63","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","volume":"18","author":"RS Garfein","year":"1998","unstructured":"Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D (1998) Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 18:S11\u2013S19","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"9296_CR64","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ije\/dyh019","volume":"33","author":"RJ Garten","year":"2004","unstructured":"Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, Yu XF (2004) Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33:182\u2013188","journal-title":"Int J Epidemiol"},{"key":"9296_CR65","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/BF02088247","volume":"41","author":"MG Ghany","year":"1996","unstructured":"Ghany MG, Leissinger C, Lagier R, Sanchez-Pescador R, Lok AS (1996) Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 41:1265\u20131272","journal-title":"Dig Dis Sci"},{"key":"9296_CR66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm1380","volume":"12","author":"Z Grossman","year":"2006","unstructured":"Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ (2006) Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 12:289\u2013295","journal-title":"Nat Med"},{"key":"9296_CR67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2310\/6650.2002.32503","volume":"50","author":"CJ Guo","year":"2002","unstructured":"Guo CJ, Li Y, Tian S, Wang X, Douglas SD, Ho WZ (2002) Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med 50:435\u2013442","journal-title":"J Investig Med"},{"key":"9296_CR68","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0091270007299760","volume":"47","author":"SK Gupta","year":"2007","unstructured":"Gupta SK, Sellers E, Somoza E, Angles L, Kolz K, Cutler DL (2007) The effect of multiple doses of peginterferon alfa-2b on the steady-state pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy. J Clin Pharmacol 47:604\u2013612","journal-title":"J Clin Pharmacol"},{"key":"9296_CR69","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nm1007-1138","volume":"13","author":"Y Han","year":"2007","unstructured":"Han Y, Siliciano RF (2007) Keeping quiet: microRNAs in HIV-1 latency. Nat Med 13:1138\u20131140","journal-title":"Nat Med"},{"key":"9296_CR70","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.bbrc.2005.09.183","volume":"337","author":"M Hariharan","year":"2005","unstructured":"Hariharan M, Scaria V, Pillai B, Brahmachari SK (2005) Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 337:1214\u20131218","journal-title":"Biochem Biophys Res Commun"},{"key":"9296_CR71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2893.1999.00175.x","volume":"6","author":"N Hayashi","year":"1999","unstructured":"Hayashi N, Mita E (1999) Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepat 6:357\u2013365","journal-title":"J Viral Hepat"},{"key":"9296_CR72","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00042737-199806000-00009","volume":"10","author":"GH Haydon","year":"1998","unstructured":"Haydon GH, Flegg PJ, Blair CS, Brettle RP, Burns SM, Hayes PC (1998) The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol 10:485\u2013489","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9296_CR73","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0022-3565(25)39585-6","volume":"267","author":"MC Hernandez","year":"1993","unstructured":"Hernandez MC, Flores LR, Bayer BM (1993) Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther 267:1336\u20131341","journal-title":"J Pharmacol Exp Ther"},{"key":"9296_CR74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/514021","volume":"176","author":"ME Hilburger","year":"1997","unstructured":"Hilburger ME, Adler MW, Truant AL, Meissler JJ Jr, Satishchandran V, Rogers TJ, Eisenstein TK (1997) Morphine induces sepsis in mice. J Infect Dis 176:183\u2013188","journal-title":"J Infect Dis"},{"key":"9296_CR75","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thx.45.12.957","volume":"45","author":"CR Hind","year":"1990","unstructured":"Hind CR (1990) Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications. Thorax 45:957\u2013961","journal-title":"Thorax"},{"key":"9296_CR76","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/jpet.103.056697","volume":"307","author":"WZ Ho","year":"2003","unstructured":"Ho WZ, Guo CJ, Yuan CS, Douglas SD, Moss J (2003) Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes. J Pharmacol Exp Ther 307:1158\u20131162","journal-title":"J Pharmacol Exp Ther"},{"key":"9296_CR77","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1639","volume":"13","author":"J Huang","year":"2007","unstructured":"Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 13:1241\u20131247","journal-title":"Nat Med"},{"key":"9296_CR78","first-page":"772","volume":"6","author":"FT Hufert","year":"1993","unstructured":"Hufert FT, Schmitz J, Schreiber M, Schmitz H, Racz P, von Laer DD (1993) Human Kupffer cells infected with HIV-1 in vivo. J Acquir Immune Defic Syndr 6:772\u2013777","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9296_CR79","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3181\/00379727-142-36968","volume":"142","author":"CY Hung","year":"1973","unstructured":"Hung CY, Lefkowitz SS, Geber WF (1973) Interferon inhibition by narcotic analgesics. Proc Soc Exp Biol Med 142:106\u2013111","journal-title":"Proc Soc Exp Biol Med"},{"key":"9296_CR80","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.07.042","volume":"54","author":"JY Jang","year":"2010","unstructured":"Jang JY, Shao RX, Lin W, Weinberg E, Chung WJ, Tsai WL, Zhao H, Goto K, Zhang L, Mendez-Navarro J, Jilg N, Peng LF, Brockman MA, Chung RT (2010) HIV infection increases HCV-induced hepatocyte apoptosis. J Hepatol 54:612\u2013620","journal-title":"J Hepatol"},{"key":"9296_CR81","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/433175","volume":"41","author":"F Kapadia","year":"2005","unstructured":"Kapadia F, Vlahov D, Donahoe RM, Friedland G (2005) The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis 41:1027\u20131034","journal-title":"Clin Infect Dis"},{"key":"9296_CR82","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF01646931","volume":"16","author":"H Koyuncuoglu","year":"1988","unstructured":"Koyuncuoglu H, Gungor M, Ang O, Inanc D, Ang-Kucuker M, Sagduyu H, Uysal V (1988) Aggravation by morphine and D-aspartic acid of pyelonephritis induced by i.v. inoculation of Staphylococcus aureus in rats. Infection 16:42\u201345","journal-title":"Infection"},{"key":"9296_CR83","first-page":"205","volume-title":"Additive states","author":"MJ Kreek","year":"1992","unstructured":"Kreek MJ (1992) Rationale for maintenance pharmacotherapy of opiate dependence. In: O\u2019Brien CP, Jaffe JH (eds) Additive states. Raven, New York, pp 205\u2013230"},{"key":"9296_CR84","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1128\/JVI.78.20.11425-11428.2004","volume":"78","author":"R Kumar","year":"2004","unstructured":"Kumar R, Torres C, Yamamura Y, Rodriguez I, Martinez M, Staprans S, Donahoe RM, Kraiselburd E, Stephens EB, Kumar A (2004) Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol 78:11425\u201311428","journal-title":"J Virol"},{"key":"9296_CR85","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.virol.2006.06.020","volume":"354","author":"R Kumar","year":"2006","unstructured":"Kumar R, Orsoni S, Norman L, Verma AS, Tirado G, Giavedoni LD, Staprans S, Miller GM, Buch SJ, Kumar A (2006) Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV\/SHIV-infected Indian rhesus macaques. Virology 354:192\u2013206","journal-title":"Virology"},{"key":"9296_CR86","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/01.aids.0000192083.41561.00","volume":"19","author":"T Laskus","year":"2005","unstructured":"Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J (2005) Emerging evidence of hepatitis C virus neuroinvasion. AIDS 19:S140\u2013S144","journal-title":"AIDS"},{"key":"9296_CR87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41\u201352","journal-title":"N Engl J Med"},{"key":"9296_CR88","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/520741","volume":"28","author":"HC Lee","year":"2007","unstructured":"Lee HC, Lee NY, Chang CM, Chou CY, Wu YH, Wang LR, Ko NY, Liu CC, Ko WC (2007) Outbreak of Acinetobacter baumannii bacteremia related to contaminated morphine used for patient-controlled analgesia. Infect Control Hosp Epidemiol 28:1213\u20131217","journal-title":"Infect Control Hosp Epidemiol"},{"key":"9296_CR89","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1086\/338011","volume":"185","author":"Y Li","year":"2002","unstructured":"Li Y, Wang X, Tian S, Guo CJ, Douglas SD, Ho WZ (2002) Methadone enhances human immunodeficiency virus infection of human immune cells. J Infect Dis 185:118\u2013122","journal-title":"J Infect Dis"},{"key":"9296_CR90","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1203\/01.PDR.0000074973.83826.4C","volume":"54","author":"Y Li","year":"2003","unstructured":"Li Y, Merrill JD, Mooney K, Song L, Wang X, Guo CJ, Savani RC, Metzger DS, Douglas SD, Ho WZ (2003a) Morphine enhances HIV infection of neonatal macrophages. Pediatr Res 54:282\u2013288","journal-title":"Pediatr Res"},{"key":"9296_CR91","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0002-9440(10)63476-1","volume":"163","author":"Y Li","year":"2003","unstructured":"Li Y, Zhang T, Douglas SD, Lai JP, Xiao WD, Pleasure DE, Ho WZ (2003b) Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 163:1167\u20131175","journal-title":"Am J Pathol"},{"key":"9296_CR92","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/520093","volume":"196","author":"Y Li","year":"2007","unstructured":"Li Y, Ye L, Peng JS, Wang CQ, Luo GX, Zhang T, Wan Q, Ho WZ (2007) Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication. J Infect Dis 196:719\u2013730","journal-title":"J Infect Dis"},{"key":"9296_CR93","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/j.gastro.2008.01.005","volume":"134","author":"W Lin","year":"2008","unstructured":"Lin W, Weinberg EM, Tai AW, Peng LF, Brockman MA, Kim KA, Kim SS, Borges CB, Shao RX, Chung RT (2008) HIV increases HCV replication in a TGF-beta1-dependent manner. Gastroenterology 134:803\u2013811","journal-title":"Gastroenterology"},{"key":"9296_CR94","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1053\/j.gastro.2010.03.008","volume":"138","author":"W Lin","year":"2010","unstructured":"Lin W, Tsai WL, Shao RX, Wu G, Peng LF, Barlow LL, Chung WJ, Zhang L, Zhao H, Jang JY, Chung RT (2010) Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology 138:2509\u20132518, 2518 e2501","journal-title":"Gastroenterology"},{"key":"9296_CR95","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1074\/jbc.M110.168286","volume":"286","author":"W Lin","year":"2011","unstructured":"Lin W, Wu G, Li S, Weinberg EM, Kumthip K, Peng LF, Mendez-Navarro J, Chen WC, Jilg N, Zhao H, Goto K, Zhang L, Brockman MA, Schuppan D, Chung RT (2011) HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB. J Biol Chem 286:2665\u20132674","journal-title":"J Biol Chem"},{"key":"9296_CR96","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2008.09.009","volume":"37","author":"AH Litwin","year":"2009","unstructured":"Litwin AH, Harris KA Jr, Nahvi S, Zamor PJ, Soloway IJ, Tenore PL, Kaswan D, Gourevitch MN, Arnsten JH (2009) Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J Subst Abuse Treat 37:32\u201340","journal-title":"J Subst Abuse Treat"},{"key":"9296_CR97","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/clinids\/16.1.182","volume":"16","author":"JM Llibre","year":"1993","unstructured":"Llibre JM, Garcia E, Aloy A, Valls J (1993) Hepatitis C virus infection and progression of infection due to human immunodeficiency virus. Clin Infect Dis 16:182","journal-title":"Clin Infect Dis"},{"key":"9296_CR98","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/brbi.1994.1003","volume":"8","author":"LL Lockwood","year":"1994","unstructured":"Lockwood LL, Silbert LH, Fleshner M, Laudenslager ML, Watkins LR, Maier SF (1994) Morphine-induced decreases in in vivo antibody responses. Brain Behav Immun 8:24\u201336","journal-title":"Brain Behav Immun"},{"key":"9296_CR99","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/aje\/kwj059","volume":"163","author":"GM Lucas","year":"2006","unstructured":"Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD (2006) Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol 163:412\u2013420","journal-title":"Am J Epidemiol"},{"key":"9296_CR100","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1086\/491736","volume":"192","author":"J Macias","year":"2005","unstructured":"Macias J, Japon MA, Saez C, Palacios RB, Mira JA, Garcia-Garcia JA, Merchante N, Vergara S, Lozano F, Gomez-Mateos J, Pineda JA (2005) Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection. J Infect Dis 192:1566\u20131576","journal-title":"J Infect Dis"},{"key":"9296_CR101","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.4049\/jimmunol.169.7.3589","volume":"169","author":"SD Mahajan","year":"2002","unstructured":"Mahajan SD, Schwartz SA, Shanahan TC, Chawda RP, Nair MP (2002) Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol 169:3589\u20133599","journal-title":"J Immunol"},{"key":"9296_CR102","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1570162054368048","volume":"3","author":"SD Mahajan","year":"2005","unstructured":"Mahajan SD, Aalinkeel R, Reynolds JL, Nair BB, Fernandez SF, Schwartz SA, Nair MP (2005) Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr HIV Res 3:277\u2013288","journal-title":"Curr HIV Res"},{"key":"9296_CR103","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1086\/367643","volume":"36","author":"C Martinez-Sierra","year":"2003","unstructured":"Martinez-Sierra C, Arizcorreta A, Diaz F, Roldan R, Martin-Herrera L, Perez-Guzman E, Giron-Gonzalez JA (2003) Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 36:491\u2013498","journal-title":"Clin Infect Dis"},{"key":"9296_CR104","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2893.2002.00339.x","volume":"9","author":"C Mathei","year":"2002","unstructured":"Mathei C, Buntinx F, van Damme P (2002) Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. J Viral Hepat 9:157\u2013173","journal-title":"J Viral Hepat"},{"key":"9296_CR105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/CDLI.8.4.690-694.2001","volume":"8","author":"JM Matthews-Greer","year":"2001","unstructured":"Matthews-Greer JM, Caldito GC, Adley SD, Willis R, Mire AC, Jamison RM, McRae KL, King JW, Chang W-L (2001) Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Diagn Lab Immunol 8:690\u2013694","journal-title":"Clin Diagn Lab Immunol"},{"key":"9296_CR106","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.20279","volume":"40","author":"S Mauss","year":"2004","unstructured":"Mauss S, Berger F, Goelz J, Jacob B, Schmutz G (2004) A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. Hepatology 40:120\u2013124","journal-title":"Hepatology"},{"key":"9296_CR107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J069v20n01_03","volume":"20","author":"JJ McCarthy","year":"2001","unstructured":"McCarthy JJ, Flynn N (2001) Hepatitis C in methadone maintenance patients: prevalence and public policy implications. J Addict Dis 20:19\u201331","journal-title":"J Addict Dis"},{"key":"9296_CR108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","volume":"62","author":"L McCarthy","year":"2001","unstructured":"McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ (2001) Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62:111\u2013123","journal-title":"Drug Alcohol Depend"},{"key":"9296_CR109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-5728(97)00217-8","volume":"83","author":"RD Mellon","year":"1998","unstructured":"Mellon RD, Bayer BM (1998) Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J Neuroimmunol 83:19\u201328","journal-title":"J Neuroimmunol"},{"key":"9296_CR110","first-page":"1049","volume":"6","author":"DS Metzger","year":"1993","unstructured":"Metzger DS, Woody GE, McLellan AT, O\u2019Brien CP, Druley P, Navaline H, DePhilippis D, Stolley P, Abrutyn E (1993) Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 6:1049\u20131056","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9296_CR111","doi-asserted-by":"crossref","first-page":"31305","DOI":"10.1074\/jbc.M001269200","volume":"275","author":"T Miyagi","year":"2000","unstructured":"Miyagi T, Chuang LF, Doi RH, Carlos MP, Torres JV, Chuang RY (2000) Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes. J Biol Chem 275:31305\u201331310","journal-title":"J Biol Chem"},{"key":"9296_CR112","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.52.7.1035","volume":"52","author":"AH Mohsen","year":"2003","unstructured":"Mohsen AH, Easterbrook PJ, Taylor C, Portmann B, Kulasegaram R, Murad S, Wiselka M, Norris S (2003) Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 52:1035\u20131040","journal-title":"Gut"},{"key":"9296_CR113","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/378643","volume":"188","author":"N Munshi","year":"2003","unstructured":"Munshi N, Balasubramanian A, Koziel M, Ganju RK, Groopman JE (2003) Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis 188:1192\u20131204","journal-title":"J Infect Dis"},{"key":"9296_CR114","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/CDLI.4.2.127-132.1997","volume":"4","author":"MP Nair","year":"1997","unstructured":"Nair MP, Schwartz SA, Polasani R, Hou J, Sweet A, Chadha KC (1997) Immunoregulatory effects of morphine on human lymphocytes. Clin Diagn Lab Immunol 4:127\u2013132","journal-title":"Clin Diagn Lab Immunol"},{"key":"9296_CR115","first-page":"437","volume":"67","author":"DM Novick","year":"2000","unstructured":"Novick DM (2000) The impact of hepatitis C virus infection on methadone maintenance treatment. Mt Sinai J Med 67:437\u2013443","journal-title":"Mt Sinai J Med"},{"key":"9296_CR116","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3565(25)22252-2","volume":"250","author":"DM Novick","year":"1989","unstructured":"Novick DM, Ochshorn M, Ghali V, Croxson TS, Mercer WD, Chiorazzi N, Kreek MJ (1989) Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther 250:606\u2013610","journal-title":"J Pharmacol Exp Ther"},{"key":"9296_CR117","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0376-8716(93)90110-C","volume":"33","author":"DM Novick","year":"1993","unstructured":"Novick DM, Richman BL, Friedman JM, Friedman JE, Fried C, Wilson JP, Townley A, Kreek MJ (1993) The medical status of methadone maintenance patients in treatment for 11\u201318\u00a0years. Drug Alcohol Depend 33:235\u2013245","journal-title":"Drug Alcohol Depend"},{"key":"9296_CR118","first-page":"534","volume-title":"Substance abuse: a comprehensive textbook","author":"DM Novick","year":"1997","unstructured":"Novick DM, Haverkos HW, Teller DW (1997) The medically ill substance abuser. In: Lowinson JM, Ruiz P, Milmam RB, Langrod JG (eds) Substance abuse: a comprehensive textbook. Williams and Wilkins, Baltimore, pp 534\u2013550"},{"key":"9296_CR119","first-page":"421","volume":"26","author":"M Ochshorn","year":"1990","unstructured":"Ochshorn M, Novick DM, Kreek MJ (1990) In vitro studies of the effect of methadone on natural killer cell activity. Isr J Med Sci 26:421\u2013425","journal-title":"Isr J Med Sci"},{"key":"9296_CR120","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.4049\/jimmunol.167.7.3677","volume":"167","author":"X Peng","year":"2001","unstructured":"Peng X, Cebra JJ, Adler MW, Meissler JJ Jr, Cowan A, Feng P, Eisenstein TK (2001) Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice. J Immunol 167:3677\u20133681","journal-title":"J Immunol"},{"key":"9296_CR121","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00002030-200305020-00011","volume":"17","author":"M Perez-Olmeda","year":"2003","unstructured":"Perez-Olmeda M, Nunez M, Romero M, Gonzalez J, Castro A, Arribas JR, Pedreira J, Barreiro P, Garcia-Samaniego J, Martin-Carbonero L, Jimenez-Nacher I, Soriano V (2003) Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 17:1023\u20131028","journal-title":"AIDS"},{"key":"9296_CR122","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/clinids\/21.5.1253","volume":"21","author":"DC Perlman","year":"1995","unstructured":"Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC (1995) Tuberculosis in drug users. Clin Infect Dis 21:1253\u20131264","journal-title":"Clin Infect Dis"},{"key":"9296_CR123","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.4049\/jimmunol.138.11.3907","volume":"138","author":"PK Peterson","year":"1987","unstructured":"Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF (1987a) Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol 138:3907\u20133912","journal-title":"J Immunol"},{"key":"9296_CR124","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1172\/JCI113140","volume":"80","author":"PK Peterson","year":"1987","unstructured":"Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF (1987b) Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest 80:824\u2013831","journal-title":"J Clin Invest"},{"key":"9296_CR125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/infdis\/159.3.480","volume":"159","author":"PK Peterson","year":"1989","unstructured":"Peterson PK, Gekker G, Brummitt C, Pentel P, Bullock M, Simpson M, Hitt J, Sharp B (1989) Suppression of human peripheral blood mononuclear cell function by methadone and morphine. J Infect Dis 159:480\u2013487","journal-title":"J Infect Dis"},{"key":"9296_CR126","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00002030-199009000-00006","volume":"4","author":"PK Peterson","year":"1990","unstructured":"Peterson PK, Sharp BM, Gekker G, Portoghese PS, Sannerud K, Balfour HH Jr (1990) Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 4:869\u2013873","journal-title":"AIDS"},{"key":"9296_CR127","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4615-2980-4_26","volume":"335","author":"PK Peterson","year":"1993","unstructured":"Peterson PK, Gekker G, Schut R, Hu S, Balfour HH Jr, Chao CC (1993) Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Adv Exp Med Biol 335:181\u2013188","journal-title":"Adv Exp Med Biol"},{"key":"9296_CR128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-5728(94)90043-4","volume":"50","author":"PK Peterson","year":"1994","unstructured":"Peterson PK, Gekker G, Hu S, Anderson WR, Kravitz F, Portoghese PS, Balfour HH Jr, Chao CC (1994) Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol 50:167\u2013175","journal-title":"J Neuroimmunol"},{"key":"9296_CR129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0960-5428(95)00020-3","volume":"5","author":"PK Peterson","year":"1995","unstructured":"Peterson PK, Gekker G, Hu S, Sheng WS, Molitor TW, Chao CC (1995) Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor. Adv Neuroimmunol 5:299\u2013309","journal-title":"Adv Neuroimmunol"},{"key":"9296_CR130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0028-3908(98)00167-1","volume":"38","author":"PK Peterson","year":"1999","unstructured":"Peterson PK, Gekker G, Hu S, Lokensgard J, Portoghese PS, Chao CC (1999) Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor. Neuropharmacology 38:273\u2013278","journal-title":"Neuropharmacology"},{"key":"9296_CR131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2003.10.026","volume":"147","author":"PK Peterson","year":"2004","unstructured":"Peterson PK, Gekker G, Hu S, Cabral G, Lokensgard JR (2004) Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures. J Neuroimmunol 147:123\u2013126","journal-title":"J Neuroimmunol"},{"key":"9296_CR132","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1300\/J069v21n04_06","volume":"21","author":"P Piccolo","year":"2002","unstructured":"Piccolo P, Borg L, Lin A, Melia D, Ho A, Kreek MJ (2002) Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. J Addict Dis 21:55\u201366","journal-title":"J Addict Dis"},{"key":"9296_CR133","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00002030-199804000-00006","volume":"12","author":"L Piroth","year":"1998","unstructured":"Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS, Grappin M, Buisson M, Waldner A, Portier H, Chavanet P (1998) Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 12:381\u2013388","journal-title":"AIDS"},{"key":"9296_CR134","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0168-8278(98)80341-3","volume":"28","author":"S Pol","year":"1998","unstructured":"Pol S, Lamorthe B, Thi NT, Thiers V, Carnot F, Zylberberg H, Berthelot P, Brechot C, Nalpas B (1998) Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 28:945\u2013950","journal-title":"J Hepatol"},{"key":"9296_CR135","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","volume":"362","author":"T Poynard","year":"2003","unstructured":"Poynard T, Yuen MF, Ratziu V, Lai CL (2003) Viral hepatitis C. Lancet 362:2095\u20132100","journal-title":"Lancet"},{"key":"9296_CR136","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1086\/375566","volume":"37","author":"G Quaglio","year":"2003","unstructured":"Quaglio G, Lugoboni F, Pajusco B, Sarti M, Talamini G, Lechi A, Mezzelani P, Des Jarlais DC (2003) Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy. Clin Infect Dis 37:33\u201340","journal-title":"Clin Infect Dis"},{"key":"9296_CR137","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0165-5728(02)00103-0","volume":"127","author":"RT Rahim","year":"2002","unstructured":"Rahim RT, Adler MW, Meissler JJ Jr, Cowan A, Rogers TJ, Geller EB, Eisenstein TK (2002) Abrupt or precipitated withdrawal from morphine induces immunosuppression. J Neuroimmunol 127:88\u201395","journal-title":"J Neuroimmunol"},{"key":"9296_CR138","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-5728(03)00273-X","volume":"144","author":"RT Rahim","year":"2003","unstructured":"Rahim RT, Meissler JJ, Zhang L, Adler MW, Rogers TJ, Eisenstein TK (2003) Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules. J Neuroimmunol 144:16\u201327","journal-title":"J Neuroimmunol"},{"key":"9296_CR139","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1189\/jlb.0304123","volume":"78","author":"RT Rahim","year":"2005","unstructured":"Rahim RT, Meissler JJ Jr, Adler MW, Eisenstein TK (2005) Splenic macrophages and B cells mediate immunosuppression following abrupt withdrawal from morphine. J Leukoc Biol 78:1185\u20131191","journal-title":"J Leukoc Biol"},{"issue":"Suppl 5","key":"9296_CR140","doi-asserted-by":"crossref","first-page":"S373","DOI":"10.1086\/427456","volume":"40","author":"J Reimer","year":"2005","unstructured":"Reimer J, Schulte B, Castells X, Schafer I, Polywka S, Hedrich D, Wiessing L, Haasen C, Backmund M, Krausz M (2005) Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries. Clin Infect Dis 40(Suppl 5):S373\u2013S378","journal-title":"Clin Infect Dis"},{"key":"9296_CR141","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3844\/ajidsp.2006.49.57","volume":"2","author":"JL Reynolds","year":"2006","unstructured":"Reynolds JL, Mahajan SD, Sykes D, Nair MP (2006) Heroin-induces differential protein expression by normal human astrocytes (NHA). Am J Infect Dis 2:49\u201357","journal-title":"Am J Infect Dis"},{"key":"9296_CR142","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(97)00216-6","volume":"83","author":"JM Risdahl","year":"1998","unstructured":"Risdahl JM, Khanna KV, Peterson PK, Molitor TW (1998) Opiates and infection. J Neuroimmunol 83:4\u201318","journal-title":"J Neuroimmunol"},{"key":"9296_CR143","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1128\/CMR.17.4.942-964.2004","volume":"17","author":"RB Rock","year":"2004","unstructured":"Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Peterson PK (2004) Role of microglia in central nervous system infections. Clin Microbiol Rev 17:942\u2013964, table of contents","journal-title":"Clin Microbiol Rev"},{"key":"9296_CR144","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/432762","volume":"192","author":"JK Rockstroh","year":"2005","unstructured":"Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J (2005) Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 192:992\u20131002","journal-title":"J Infect Dis"},{"key":"9296_CR145","unstructured":"Rodriguez JW, Hunter R, Nair MP, Rios-Olivares E (2007) Increase T-regulatory cell number and expression of CXCR4 and mu-opioids on CD4+ T-cells by methadone is associated with enhancemment of HIV-1 infectivity. J Immunol 178: B17"},{"key":"9296_CR146","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00002030-199403000-00007","volume":"8","author":"PJ Ronald","year":"1994","unstructured":"Ronald PJ, Robertson JR, Elton RA (1994) Continued drug use and other cofactors for progression to AIDS among injecting drug users. AIDS 8:339\u2013343","journal-title":"AIDS"},{"key":"9296_CR147","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1128\/JVI.00191-09","volume":"83","author":"Y Rotman","year":"2009","unstructured":"Rotman Y, Liang TJ (2009) Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol 83:7366\u20137374","journal-title":"J Virol"},{"key":"9296_CR148","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-5728(98)00265-3","volume":"95","author":"S Roy","year":"1999","unstructured":"Roy S, Charboneau RG, Barke RA (1999) Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model. J Neuroimmunol 95:107\u2013114","journal-title":"J Neuroimmunol"},{"key":"9296_CR149","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0168-8278(02)00418-X","volume":"38","author":"C Royer","year":"2003","unstructured":"Royer C, Steffan AM, Navas MC, Fuchs A, Jaeck D, Stoll-Keller F (2003) A study of susceptibility of primary human Kupffer cells to hepatitis C virus. J Hepatol 38:250\u2013256","journal-title":"J Hepatol"},{"key":"9296_CR150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1874473710801020177","volume":"1","author":"M Schaefer","year":"2008","unstructured":"Schaefer M, Mauss S (2008) Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. Curr Drug Abuse Rev 1:177\u2013187","journal-title":"Curr Drug Abuse Rev"},{"key":"9296_CR151","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1360-0443.2004.00821.x","volume":"99","author":"M Schaefer","year":"2004","unstructured":"Schaefer M, Heinz A, Backmund M (2004) Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 99:1167\u20131175","journal-title":"Addiction"},{"key":"9296_CR152","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1089\/aid.1990.6.987","volume":"6","author":"MP Schmitt","year":"1990","unstructured":"Schmitt MP, Gendrault JL, Schweitzer C, Steffan AM, Beyer C, Royer C, Jaeck D, Pasquali JL, Kirn A, Aubertin AM (1990) Permissivity of primary cultures of human Kupffer cells for HIV-1. AIDS Res Hum Retroviruses 6:987\u2013991","journal-title":"AIDS Res Hum Retroviruses"},{"key":"9296_CR153","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.gastro.2005.03.089","volume":"129","author":"A Schulze-Krebs","year":"2005","unstructured":"Schulze-Krebs A, Preimel D, Popov Y, Bartenschlager R, Lohmann V, Pinzani M, Schuppan D (2005) Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology 129:246\u2013258","journal-title":"Gastroenterology"},{"key":"9296_CR154","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0923-2516(91)90056-9","volume":"142","author":"C Schweitzer","year":"1991","unstructured":"Schweitzer C, Keller F, Schmitt MP, Jaeck D, Adloff M, Schmitt C, Royer C, Kirn A, Aubertin AM (1991) Morphine stimulates HIV replication in primary cultures of human Kupffer cells. Res Virol 142:189\u2013195","journal-title":"Res Virol"},{"key":"9296_CR155","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/500938","volume":"42","author":"JD Scott","year":"2006","unstructured":"Scott JD, McMahon BJ, Bruden D, Sullivan D, Homan C, Christensen C, Gretch DR (2006) High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clin Infect Dis 42:945\u2013952","journal-title":"Clin Infect Dis"},{"key":"9296_CR156","first-page":"16","volume":"47","author":"LM Selimova","year":"2002","unstructured":"Selimova LM, Khanina TA, Kazennova EV, Zverev S, Pokrovskii VV, Bobkov AF (2002) Effect of heroin-containing substances on the infectivity of the human immunodeficiency virus type 1 in vitro. Vopr Virusol 47:16\u201320","journal-title":"Vopr Virusol"},{"key":"9296_CR157","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1467-842X.1997.tb01664.x","volume":"21","author":"LA Selvey","year":"1997","unstructured":"Selvey LA, Denton M, Plant AJ (1997) Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus. Aust N Z J Public Health 21:102\u2013104","journal-title":"Aust N Z J Public Health"},{"key":"9296_CR158","first-page":"492","volume":"108","author":"PA Selwyn","year":"1993","unstructured":"Selwyn PA, Budner NS, Wasserman WC, Arno PS (1993) Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Rep 108:492\u2013500","journal-title":"Public Health Rep"},{"key":"9296_CR159","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/339042","volume":"34","author":"KE Sherman","year":"2002","unstructured":"Sherman KE, Rouster SD, Chung RT, Rajicic N (2002) Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 34:831\u2013837","journal-title":"Clin Infect Dis"},{"key":"9296_CR160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00075198-200104000-00008","volume":"7","author":"K Sheth","year":"2001","unstructured":"Sheth K, Bankey P (2001) The liver as an immune organ. Curr Opin Crit Care 7:99\u2013104","journal-title":"Curr Opin Crit Care"},{"key":"9296_CR161","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ije\/dyh347","volume":"34","author":"BP Smyth","year":"2005","unstructured":"Smyth BP, Barry J, Keenan E (2005) Irish injecting drug users and hepatitis C: the importance of the social context of injecting. Int J Epidemiol 34:166\u2013172","journal-title":"Int J Epidemiol"},{"key":"9296_CR162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","volume":"26","author":"B Soto","year":"1997","unstructured":"Soto B, Sanchez-Quijano A, Rodrigo L, del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, Rey C, Abad MA, Rodriguez M, Sales Gilabert M, Gonzalez F, Miron P, Caruz A, Relimpio F, Torronteras R, Leal M, Lissen E (1997) Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 26:1\u20135","journal-title":"J Hepatol"},{"key":"9296_CR163","first-page":"485","volume":"81","author":"S Specter","year":"1994","unstructured":"Specter S (1994) Drugs of abuse and infectious diseases. J Fla Med Assoc 81:485\u2013487","journal-title":"J Fla Med Assoc"},{"key":"9296_CR164","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1089\/aid.1990.6.1163","volume":"6","author":"SP Squinto","year":"1990","unstructured":"Squinto SP, Mondal D, Block AL, Prakash O (1990) Morphine-induced transactivation of HIV-1 LTR in human neuroblastoma cells. AIDS Res Hum Retroviruses 6:1163\u20131168","journal-title":"AIDS Res Hum Retroviruses"},{"key":"9296_CR165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1086\/520144","volume":"29","author":"CT Staples Jr","year":"1999","unstructured":"Staples CT Jr, Rimland D, Dudas D (1999) Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis 29:150\u2013154","journal-title":"Clin Infect Dis"},{"key":"9296_CR166","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0042-6822(03)00015-1","volume":"309","author":"AD Steele","year":"2003","unstructured":"Steele AD, Henderson EE, Rogers TJ (2003) Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 309:99\u2013107","journal-title":"Virology"},{"key":"9296_CR167","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","volume":"281","author":"EC Strain","year":"1999","unstructured":"Strain EC, Bigelow GE, Liebson IA, Stitzer ML (1999) Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. Jama 281:1000\u20131005","journal-title":"Jama"},{"key":"9296_CR168","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-138-3-200302040-00012","volume":"138","author":"MS Sulkowski","year":"2003","unstructured":"Sulkowski MS, Thomas DL (2003) Hepatitis C in the HIV-Infected Person. Ann Intern Med 138:197\u2013207","journal-title":"Ann Intern Med"},{"key":"9296_CR169","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.288.2.199","volume":"288","author":"MS Sulkowski","year":"2002","unstructured":"Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL (2002) Hepatitis C and progression of HIV disease. JAMA 288:199\u2013206","journal-title":"JAMA"},{"key":"9296_CR170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsat.2007.08.004","volume":"35","author":"LE Sullivan","year":"2008","unstructured":"Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O\u2019Connor PG, Schottenfeld RS, Fiellin DA (2008) Buprenorphine\/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat 35:87\u201392","journal-title":"J Subst Abuse Treat"},{"key":"9296_CR171","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1086\/340816","volume":"185","author":"S Suzuki","year":"2002","unstructured":"Suzuki S, Chuang AJ, Chuang LF, Doi RH, Chuang RY (2002a) Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry. J Infect Dis 185:1826\u20131829","journal-title":"J Infect Dis"},{"key":"9296_CR172","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/excr.2002.5638","volume":"280","author":"S Suzuki","year":"2002","unstructured":"Suzuki S, Chuang LF, Yau P, Doi RH, Chuang RY (2002b) Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp Cell Res 280:192\u2013200","journal-title":"Exp Cell Res"},{"key":"9296_CR173","doi-asserted-by":"crossref","unstructured":"Suzuki S, Carlos MP, Chuang LF, Torres JV, Doi RH, Chuang RY (2002c) Methadone induces CCR5 and promotes AIDS virus infection. FEBS Lett 519:173-177","DOI":"10.1016\/S0014-5793(02)02746-1"},{"key":"9296_CR174","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/MEG.0b013e3281bcb8d8","volume":"19","author":"DL Sylvestre","year":"2007","unstructured":"Sylvestre DL, Clements BJ (2007) Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. Eur J Gastroenterol Hepatol 19:741\u2013747","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9296_CR175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3565(25)39466-8","volume":"267","author":"I Szabo","year":"1993","unstructured":"Szabo I, Rojavin M, Bussiere JL, Eisenstein TK, Adler MW, Rogers TJ (1993) Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther 267:703\u2013706","journal-title":"J Pharmacol Exp Ther"},{"key":"9296_CR176","doi-asserted-by":"crossref","unstructured":"Szabo I, Wetzel MA, Zhang N, Steele AD, Kaminsky DE, Chen C, Liu-Chen LY, Bednar F, Henderson EE, Howard OM, Oppenheim JJ, Rogers TJ (2003) Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol 74: 1074-82","DOI":"10.1189\/jlb.0203067"},{"key":"9296_CR177","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.187.6.949","volume":"187","author":"K Tenner-Racz","year":"1998","unstructured":"Tenner-Racz K, Stellbrink HJ, van Lunzen J, Schneider C, Jacobs JP, Raschdorff B, Grosschupff G, Steinman RM, Racz P (1998) The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med 187:949\u2013959","journal-title":"J Exp Med"},{"key":"9296_CR178","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","volume":"194","author":"R Thimme","year":"2002","unstructured":"Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV (2002) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395\u20131406","journal-title":"J Exp Med"},{"key":"9296_CR179","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/169.5.990","volume":"169","author":"DL Thomas","year":"1994","unstructured":"Thomas DL, Cannon RO, Shapiro CN, Hook EW 3rd, Alter MJ, Quinn TC (1994) Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 169:990\u2013995","journal-title":"J Infect Dis"},{"key":"9296_CR180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","volume":"74","author":"DL Thomas","year":"1995","unstructured":"Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE (1995) Correlates of hepatitis C virus infections among injection drug users. [Review] [31 refs]. Medicine 74:212\u2013220","journal-title":"Medicine"},{"key":"9296_CR181","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/infdis\/174.4.690","volume":"174","author":"DL Thomas","year":"1996","unstructured":"Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE (1996) Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 174:690\u2013695","journal-title":"J Infect Dis"},{"key":"9296_CR182","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","volume":"351","author":"FJ Torriani","year":"2004","unstructured":"Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-Garcia J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H Jr, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT (2004) Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 351:438\u2013450","journal-title":"N Engl J Med"},{"key":"9296_CR183","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/infdis\/148.4.656","volume":"148","author":"E Tubaro","year":"1983","unstructured":"Tubaro E, Borelli G, Croce C, Cavallo G, Santiangeli C (1983) Effect of morphine on resistance to infection. J Infect Dis 148:656\u2013666","journal-title":"J Infect Dis"},{"key":"9296_CR184","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0376-8716(02)00325-3","volume":"69","author":"A Umbricht","year":"2003","unstructured":"Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL (2003) Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend 69:263\u2013272","journal-title":"Drug Alcohol Depend"},{"key":"9296_CR185","first-page":"81","volume":"68","author":"R Verrando","year":"2005","unstructured":"Verrando R, Robaeys G, Mathei C, Buntinx F (2005) Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use. Acta Gastroenterol Belg 68:81\u201385","journal-title":"Acta Gastroenterol Belg"},{"key":"9296_CR186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2008.04.026","volume":"199","author":"Q Wan","year":"2008","unstructured":"Wan Q, Wang X, Wang YJ, Song L, Wang SH, Ho WZ (2008) Morphine suppresses intracellular interferon-alpha expression in neuronal cells. J Neuroimmunol 199:1\u20139","journal-title":"J Neuroimmunol"},{"key":"9296_CR187","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1189\/jlb.71.5.782","volume":"71","author":"J Wang","year":"2002","unstructured":"Wang J, Charboneau R, Balasubramanian S, Barke RA, Loh HH, Roy S (2002) The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J Leukoc Biol 71:782\u2013790","journal-title":"J Leukoc Biol"},{"key":"9296_CR188","doi-asserted-by":"crossref","first-page":"37622","DOI":"10.1074\/jbc.M301224200","volume":"278","author":"J Wang","year":"2003","unstructured":"Wang J, Barke RA, Charboneau R, Loh HH, Roy S (2003) Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J Biol Chem 278:37622\u201337631","journal-title":"J Biol Chem"},{"key":"9296_CR189","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0002-9440(10)61220-5","volume":"167","author":"CQ Wang","year":"2005","unstructured":"Wang CQ, Li Y, Douglas SD, Wang X, Metzger DS, Zhang T, Ho WZ (2005a) Morphine withdrawal enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 167:1333\u20131340","journal-title":"Am J Pathol"},{"key":"9296_CR190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4049\/jimmunol.174.1.426","volume":"174","author":"J Wang","year":"2005","unstructured":"Wang J, Barke RA, Charboneau R, Roy S (2005b) Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 174:426\u2013434","journal-title":"J Immunol"},{"key":"9296_CR191","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1189\/jlb.0305167","volume":"78","author":"X Wang","year":"2005","unstructured":"Wang X, Tan N, Douglas SD, Zhang T, Wang YJ, Ho WZ (2005c) Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells. J Leukoc Biol 78:772\u2013776","journal-title":"J Leukoc Biol"},{"key":"9296_CR192","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2353\/ajpath.2006.060358","volume":"169","author":"X Wang","year":"2006","unstructured":"Wang X, Douglas SD, Peng JS, Zhou DJ, Wan Q, Ho WZ (2006) An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P. Am J Pathol 169:1663\u20131670","journal-title":"Am J Pathol"},{"key":"9296_CR193","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.180.5.3594","volume":"180","author":"J Wang","year":"2008","unstructured":"Wang J, Barke RA, Charboneau R, Schwendener R, Roy S (2008a) Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling. J Immunol 180:3594\u20133600","journal-title":"J Immunol"},{"key":"9296_CR194","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00005-008-0035-0","volume":"56","author":"J Wang","year":"2008","unstructured":"Wang J, Barke RA, Ma J, Charboneau R, Roy S (2008b) Opiate abuse, innate immunity, and bacterial infectious diseases. Arch Immunol Ther Exp (Warsz) 56:299\u2013309","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"9296_CR195","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood-2008-09-175000","volume":"113","author":"X Wang","year":"2009","unstructured":"Wang X, Ye L, Hou W, Zhou Y, Wang YJ, Metzger DS, Ho WZ (2009) Cellular microRNA expression correlates with susceptibility of monocytes\/macrophages to HIV-1 infection. Blood 113:671\u2013674","journal-title":"Blood"},{"key":"9296_CR196","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ajpath.2010.11.042","volume":"178","author":"X Wang","year":"2011","unstructured":"Wang X, Ye L, Zhou Y, Liu MQ, Zhou DJ, Ho WZ (2011) Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am J Pathol 178:41\u201347","journal-title":"Am J Pathol"},{"key":"9296_CR197","doi-asserted-by":"crossref","first-page":"e9602","DOI":"10.1371\/journal.pone.0009602","volume":"5","author":"L Ye","year":"2010","unstructured":"Ye L, Wang X, Metzger DS, Riedel E, Montaner LJ, Ho W (2010) Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users. PLoS One 5:e9602","journal-title":"PLoS One"},{"key":"9296_CR198","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0168-8278(02)00209-X","volume":"37","author":"JH Yoon","year":"2002","unstructured":"Yoon JH, Gores GJ (2002) Death receptor-mediated apoptosis and the liver. J Hepatol 37:400\u2013410","journal-title":"J Hepatol"},{"key":"9296_CR199","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0149-2918(11)00021-X","volume":"32","author":"B Zanini","year":"2010","unstructured":"Zanini B, Covolo L, Donato F, Lanzini A (2010) Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies. Clin Ther 32:2139\u20132159","journal-title":"Clin Ther"},{"key":"9296_CR200","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2105\/AJPH.90.7.1100","volume":"90","author":"GS Zaric","year":"2000","unstructured":"Zaric GS, Barnett PG, Brandeau ML (2000) HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health 90:1100\u20131111","journal-title":"Am J Public Health"},{"key":"9296_CR201","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/rmv.508","volume":"16","author":"T Zhang","year":"2006","unstructured":"Zhang T, Li Y, Ho WZ (2006) Drug abuse, innate immunity and hepatitis C virus. Rev Med Virol 16:311\u2013327","journal-title":"Rev Med Virol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-011-9296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-011-9296-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-011-9296-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T02:29:22Z","timestamp":1741314562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-011-9296-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,14]]},"references-count":201,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9296"],"URL":"https:\/\/doi.org\/10.1007\/s11481-011-9296-1","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,14]]}}}